RCE 0.00% 46.0¢ recce pharmaceuticals ltd

Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection, page-101

  1. 5,334 Posts.
    lightbulb Created with Sketch. 685
    I was hoping after initial batch there would have been a notice of no adverse events. Maybe it takes time to collate data, and also maybe there are some reactions that they are yet to decide if they are classed as adverse? I would guess patients may "feel" something different but they may not know for some time if it is a reaction or any detrimental effect? Maybe they are still waiting for confirmation all is ok with initial batch. One would have to assume if second cohort proceeds then first must have been deemed safe, but I guess we have no conformation second cohort is going ahead so who knows.
    Bottom line seems to be surely if there had Ben a serious adverse effect they would have been obliged to notify when they became aware.
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
46.0¢
Change
0.000(0.00%)
Mkt cap ! $102.0M
Open High Low Value Volume
46.0¢ 46.5¢ 46.0¢ $19.60K 42.56K

Buyers (Bids)

No. Vol. Price($)
3 41004 46.0¢
 

Sellers (Offers)

Price($) Vol. No.
46.5¢ 38272 2
View Market Depth
Last trade - 15.56pm 26/07/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.